CGBSF (CGBSF) Stock Price & Analysis
CGBSF (CGBSF) rose 0.00% to USD 0 as of June 10, 2026 at 01:07 UTC, according to Nexqual real-time market data.
CGBSF last closed at USD 0; the session ranged USD 0–0 on volume of 21,643 shares. Market capitalization is $48,941, with a 52-week range of USD 0–0.17 (PNK). Source: Nexqual, June 10, 2026 at 01:07 UTC.
Key Statistics (as of June 10, 2026 at 01:07 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.17 |
| Volume | 21,643 shares |
| Market Cap | $48,941 |
| Exchange | PNK |
Technical Analysis (CGBSF)
Nexqual's technical model rates CGBSF "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 01:07 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (CGBSF)
Wall Street analysts rate CGBSF "None", per Nexqual as of June 10, 2026 at 01:07 UTC.
| Consensus Rating | None |
|---|
Earnings (CGBSF)
Source: Nexqual, June 10, 2026 at 01:07 UTC.
Financials & Fundamentals (CGBSF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Debt / Equity | 8.36 |
| Current Ratio | 0.01 |
| Total Cash | $34,000 |
| Total Debt | $2.02M |
Source: Nexqual, June 10, 2026 at 01:07 UTC.
Financial Health Score (CGBSF)
Nexqual rates CGBSF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 01:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Solid — $34K cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$1M |
| Efficiency | Mixed — No data |
Ownership (CGBSF)
| Insider Ownership | +47.67% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 489.42M |
| Float | 31.43M |
| Short % of Float | +3.45% |
Source: Nexqual, June 10, 2026 at 01:07 UTC.
Leadership (CGBSF)
CGBSF is led by Swapan Kataria (age 51), CEO & Director, per Nexqual as of June 10, 2026 at 01:07 UTC.
| CEO & Director | Swapan Kataria (age 51) |
|---|---|
| CFO & Director | Jorn Skule Husemoen (age 61) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NIVF | NewGenIvf Group Limited | USD 0.49 | ▼ 22.88% |
| VTAK | Catheter Precision, Inc. | USD 1 | ▼ 3.2% |
| AZTR | Azitra Inc | USD 0.21 | ▲ 0.62% |
| ATPC | Agape ATP Corporation | USD 3.12 | ▲ 4.7% |
| BSLK | Bolt Projects Holdings, Inc. | USD 0.05 | ▼ 24.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:07 UTC. This page is informational and not investment advice.